Ming Hsieh | Chief Executive Officer |
Nicole Borsje | Investor Relations |
Paul Kim | Chief Financial Officer |
Larry Weiss | Chief Medical Officer |
Brandon Perthuis | Chief Commercial Officer |
Kevin DeGeeter | Oppenheimer |
Good day and welcome to the Fulgent Genetics Third Quarter 2021 Earnings Conference Call. At this time, I would like to turn the conference over to Nicole Borsje, Investor Relations, please go ahead, ma'am.
Great. Thanks. Good afternoon and welcome to the Fulgent Genetics, third quarter 2021 financial results conference call.